TO BE UPDATED WITH 2023
the call for Technology and Innovation is now closed.
The results will be announced mid-February.
For clinicians, scientists or engineers.
The invention or innovation should be on the broad topic of cardiac arrhythmias and tackle a novel approach. It could be a developed software, a new device, a new use for a drug or other small molecule, or bringing a business approach to an aspect of cardiac rhythm management that can be considered an invention.
All pre-commercial revenue stages will be considered, so the idea may be still in basic research, or have progressed all the way to early clinical trials, but it should have moved beyond the idea stage.
- Monday, 25 October 2021 - Wednesday, 12 January 2022: Submission period
- Wednesday 19 January 2022 - Extended submission deadline
- Mid-February: Results announcement. An email will also be sent to each submitter.
Preparing your submission
- Review the Technology and Innovation submission rules and guidelines
- The online submission has been optimised - Browser configuration
Format of the session
The top three presenters will present their innovation during 12 minutes followed by 5 minutes discussion.
Instructions and guidelines concerning the presentation will be provided to the presenters at the time of results announcement, including the options for presentation in person at the congress venue in Copenhagen, Denmark.
The top three presenters will be awarded a free registration to attend EHRA 2022 and EHRA 2023.